Physician profile
Mohammad Hout
NPI 1508483496
$4,682.71
in general payments reported to CMS, 2019-2025
10 companies · $109 in 2025
The $109 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $25.44 · 2023: $3,639 · 2024: $910 · 2025: $109.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,550 · Food and Beverage: $1,049 · Education: $35.06 · Gift: $22.84.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,550.18 |
| Food and Beverage | $1,049.19 |
| Education | $35.06 |
| Gift | $22.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $3,196.82 | 2023-2024 | Da Vinci Surgical System, Da Vinci Sp |
| Boston Scientific Corporation | $1,069.28 | 2023 | Moses 550 D\F\L, Lithovue |
| Teleflex LLC | $96.65 | 2023 | Urolift |
| Laborie Medical Technologies Corp. | $78.75 | 2023 | |
| Astrazeneca Pharmaceuticals LP | $60.50 | 2022-2025 | Imfinzi |
| Conmed Corporation | $47.83 | 2023 | Airseal |
| Stryker Corporation | $41.80 | 2025 | 1788 |
| W. L. Gore & Associates, INC. | $36.85 | 2024 | Gore Synecor Biomaterial |
| 180 Medical, INC. | $31.73 | 2025 | |
| Urogen Pharma, INC. | $22.50 | 2023 | Jelmyto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mohammad Hout listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.